Public Policy

CDSCO cancels 7 clinical trial ethics panels over serious violations

· 26 July 2026 · 2 min read
CDSCO cancels 7 clinical trial ethics panels over serious violations

The Times of India has reported a new India-focused policy development: “CDSCO cancels 7 clinical trial ethics panels over serious violations.” The publisher's feed describes the story as follows: <![CDATA[India's drug regulator cancelled seven Ethics Committee registrations nationwide. Inspections revealed serious violations of clinical trial rules and guidelines. These committees oversee participant rights and safety during medical studies. The action followed a thorough compliance assessment

Original reporting by The Times of IndiaRead the full story

Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.

#policy#india#governance

Related reading

IJP
News Brief
The case for accountable lottery regulation in India
Public Policy·The Hindu·25 Sep 2026

The case for accountable lottery regulation in India

Read full story →
IJP
News Brief
Actis merges 11 India road assets into $1 billion trust
Public Policy·The Economic Times·25 Sep 2026

Actis merges 11 India road assets into $1 billion trust

Read full story →
IJP
News Brief
The murky world of political party finance
Public Policy·The Hindu·25 Sep 2026

The murky world of political party finance

Read full story →
IJP
News Brief
India’s growth outlook strengthens as economists see resilient incomes, stable policy: WEF
Public Policy·Mint·25 Sep 2026

India’s growth outlook strengthens as economists see resilient incomes, stable policy: WEF

Read full story →